Filing Details
- Accession Number:
- 0001209191-16-106323
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-07 08:03:31
- Reporting Period:
- 2016-03-04
- Filing Date:
- 2016-03-07
- Accepted Time:
- 2016-03-07 08:03:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1253689 | Glycomimetics Inc | GLYC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532475 | Alan Mark Goldberg | C/O Glycomimetics, Inc. 9708 Medical Center Drive Rockville MD 20850 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-03-04 | 10,397 | $4.77 | 11,497 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The common stock was purchased by the reporting person in a series of open market transactions on the transaction date with a volume weighted average purchase price of $4.7735. The range of purchase prices for the transactions reported was $4.61 to $4.924 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
